nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—OPRM1—nicotine dependence	0.785	1	CbGaD
Fentanyl—Postnasal drip—Varenicline—nicotine dependence	0.00759	0.0405	CcSEcCtD
Fentanyl—Upper-airway cough syndrome—Varenicline—nicotine dependence	0.00643	0.0343	CcSEcCtD
Fentanyl—Chest wall pain—Varenicline—nicotine dependence	0.00643	0.0343	CcSEcCtD
Fentanyl—Gingival pain—Varenicline—nicotine dependence	0.00538	0.0287	CcSEcCtD
Fentanyl—Facial paralysis—Varenicline—nicotine dependence	0.00369	0.0197	CcSEcCtD
Fentanyl—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.00303	0.0162	CcSEcCtD
Fentanyl—Drug hypersensitivity—Varenicline—nicotine dependence	0.00292	0.0156	CcSEcCtD
Fentanyl—Withdrawal symptom—Varenicline—nicotine dependence	0.00286	0.0153	CcSEcCtD
Fentanyl—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00286	0.0153	CcSEcCtD
Fentanyl—Dysphoria—Varenicline—nicotine dependence	0.00272	0.0145	CcSEcCtD
Fentanyl—Aphthous stomatitis—Varenicline—nicotine dependence	0.0025	0.0134	CcSEcCtD
Fentanyl—Peripheral vascular disorder—Varenicline—nicotine dependence	0.00239	0.0128	CcSEcCtD
Fentanyl—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00239	0.0128	CcSEcCtD
Fentanyl—Throat irritation—Varenicline—nicotine dependence	0.00233	0.0124	CcSEcCtD
Fentanyl—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00226	0.0121	CcSEcCtD
Fentanyl—Night sweats—Varenicline—nicotine dependence	0.00218	0.0116	CcSEcCtD
Fentanyl—Balance disorder—Varenicline—nicotine dependence	0.00215	0.0115	CcSEcCtD
Fentanyl—Hostility—Varenicline—nicotine dependence	0.00212	0.0113	CcSEcCtD
Fentanyl—Sexual dysfunction—Varenicline—nicotine dependence	0.00209	0.0112	CcSEcCtD
Fentanyl—Platelet count decreased—Varenicline—nicotine dependence	0.00197	0.0105	CcSEcCtD
Fentanyl—Parosmia—Varenicline—nicotine dependence	0.00181	0.00966	CcSEcCtD
Fentanyl—Trimethaphan—CHRNA10—nicotine dependence	0.0018	0.191	CrCbGaD
Fentanyl—Upset stomach—Varenicline—nicotine dependence	0.00179	0.00956	CcSEcCtD
Fentanyl—Cyst—Varenicline—nicotine dependence	0.00176	0.00937	CcSEcCtD
Fentanyl—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00174	0.00928	CcSEcCtD
Fentanyl—Laryngeal pain—Varenicline—nicotine dependence	0.00172	0.00919	CcSEcCtD
Fentanyl—Paranoia—Varenicline—nicotine dependence	0.00172	0.00919	CcSEcCtD
Fentanyl—Intestinal obstruction—Varenicline—nicotine dependence	0.00172	0.00919	CcSEcCtD
Fentanyl—Haematemesis—Varenicline—nicotine dependence	0.00169	0.00902	CcSEcCtD
Fentanyl—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00156	0.00832	CcSEcCtD
Fentanyl—Fungal infection—Varenicline—nicotine dependence	0.00152	0.00811	CcSEcCtD
Fentanyl—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0015	0.0837	CbGpPWpGaD
Fentanyl—Gingivitis—Varenicline—nicotine dependence	0.0015	0.00798	CcSEcCtD
Fentanyl—Rhinorrhoea—Varenicline—nicotine dependence	0.00145	0.00773	CcSEcCtD
Fentanyl—Dysphonia—Varenicline—nicotine dependence	0.00143	0.00762	CcSEcCtD
Fentanyl—Endocrine disorder—Varenicline—nicotine dependence	0.00142	0.00756	CcSEcCtD
Fentanyl—Disturbance in attention—Varenicline—nicotine dependence	0.00136	0.00723	CcSEcCtD
Fentanyl—Accidental injury—Varenicline—nicotine dependence	0.00133	0.00708	CcSEcCtD
Fentanyl—Chest discomfort—Varenicline—nicotine dependence	0.00133	0.00708	CcSEcCtD
Fentanyl—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0013	0.00694	CcSEcCtD
Fentanyl—Viral infection—Varenicline—nicotine dependence	0.0013	0.00694	CcSEcCtD
Fentanyl—Trimethaphan—CHRNB4—nicotine dependence	0.00129	0.137	CrCbGaD
Fentanyl—Thinking abnormal—Varenicline—nicotine dependence	0.00128	0.00684	CcSEcCtD
Fentanyl—Nocturia—Varenicline—nicotine dependence	0.00127	0.00675	CcSEcCtD
Fentanyl—Dysarthria—Varenicline—nicotine dependence	0.00124	0.00662	CcSEcCtD
Fentanyl—Coordination abnormal—Varenicline—nicotine dependence	0.0012	0.00638	CcSEcCtD
Fentanyl—Musculoskeletal pain—Varenicline—nicotine dependence	0.00119	0.00634	CcSEcCtD
Fentanyl—Blood pressure increased—Varenicline—nicotine dependence	0.00117	0.00627	CcSEcCtD
Fentanyl—Pulmonary embolism—Varenicline—nicotine dependence	0.00117	0.00627	CcSEcCtD
Fentanyl—Abnormal dreams—Varenicline—nicotine dependence	0.00116	0.00619	CcSEcCtD
Fentanyl—Eructation—Varenicline—nicotine dependence	0.00115	0.00616	CcSEcCtD
Fentanyl—Influenza like illness—Varenicline—nicotine dependence	0.00114	0.00608	CcSEcCtD
Fentanyl—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00109	0.0605	CbGpPWpGaD
Fentanyl—Dry eye—Varenicline—nicotine dependence	0.00108	0.00579	CcSEcCtD
Fentanyl—Oesophagitis—Varenicline—nicotine dependence	0.00107	0.00572	CcSEcCtD
Fentanyl—Mouth ulceration—Varenicline—nicotine dependence	0.00106	0.00566	CcSEcCtD
Fentanyl—Urine output increased—Varenicline—nicotine dependence	0.00106	0.00566	CcSEcCtD
Fentanyl—Hypertonia—Varenicline—nicotine dependence	0.00103	0.00549	CcSEcCtD
Fentanyl—Mental disability—Varenicline—nicotine dependence	0.00102	0.00544	CcSEcCtD
Fentanyl—Euphoric mood—Varenicline—nicotine dependence	0.00101	0.00538	CcSEcCtD
Fentanyl—Lymphadenopathy—Varenicline—nicotine dependence	0.000999	0.00533	CcSEcCtD
Fentanyl—Sleep disorder—Varenicline—nicotine dependence	0.000985	0.00525	CcSEcCtD
Fentanyl—Polyuria—Varenicline—nicotine dependence	0.000971	0.00518	CcSEcCtD
Fentanyl—Disorientation—Varenicline—nicotine dependence	0.000953	0.00508	CcSEcCtD
Fentanyl—Eczema—Varenicline—nicotine dependence	0.000949	0.00506	CcSEcCtD
Fentanyl—Injury—Varenicline—nicotine dependence	0.000927	0.00495	CcSEcCtD
Fentanyl—Libido decreased—Varenicline—nicotine dependence	0.000919	0.0049	CcSEcCtD
Fentanyl—Hot flush—Varenicline—nicotine dependence	0.000911	0.00486	CcSEcCtD
Fentanyl—Increased appetite—Varenicline—nicotine dependence	0.000907	0.00484	CcSEcCtD
Fentanyl—Amnesia—Varenicline—nicotine dependence	0.000907	0.00484	CcSEcCtD
Fentanyl—Menopausal symptoms—Varenicline—nicotine dependence	0.000903	0.00482	CcSEcCtD
Fentanyl—Visual disturbance—Varenicline—nicotine dependence	0.0009	0.0048	CcSEcCtD
Fentanyl—Trimethaphan—CHRNA3—nicotine dependence	0.000896	0.095	CrCbGaD
Fentanyl—Thirst—Varenicline—nicotine dependence	0.000896	0.00478	CcSEcCtD
Fentanyl—Arthritis—Varenicline—nicotine dependence	0.000877	0.00468	CcSEcCtD
Fentanyl—Hypoglycaemia—Varenicline—nicotine dependence	0.000873	0.00466	CcSEcCtD
Fentanyl—Lethargy—Varenicline—nicotine dependence	0.00087	0.00464	CcSEcCtD
Fentanyl—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.000852	0.00455	CcSEcCtD
Fentanyl—Osteoarthritis—Varenicline—nicotine dependence	0.000852	0.00455	CcSEcCtD
Fentanyl—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.000846	0.00451	CcSEcCtD
Fentanyl—Affect lability—Varenicline—nicotine dependence	0.000839	0.00448	CcSEcCtD
Fentanyl—Psychotic disorder—Varenicline—nicotine dependence	0.000833	0.00444	CcSEcCtD
Fentanyl—Irritability—Varenicline—nicotine dependence	0.000814	0.00434	CcSEcCtD
Fentanyl—Urinary retention—Varenicline—nicotine dependence	0.000811	0.00432	CcSEcCtD
Fentanyl—Mood swings—Varenicline—nicotine dependence	0.000808	0.00431	CcSEcCtD
Fentanyl—Difenoxin—OPRM1—nicotine dependence	0.000784	0.0831	CrCbGaD
Fentanyl—Remifentanil—OPRM1—nicotine dependence	0.000784	0.0831	CrCbGaD
Fentanyl—Abdominal pain upper—Varenicline—nicotine dependence	0.000779	0.00415	CcSEcCtD
Fentanyl—Hypokalaemia—Varenicline—nicotine dependence	0.000776	0.00414	CcSEcCtD
Fentanyl—Breast disorder—Varenicline—nicotine dependence	0.00077	0.00411	CcSEcCtD
Fentanyl—Anileridine—OPRM1—nicotine dependence	0.000764	0.081	CrCbGaD
Fentanyl—Nasopharyngitis—Varenicline—nicotine dependence	0.000762	0.00407	CcSEcCtD
Fentanyl—Gastritis—Varenicline—nicotine dependence	0.000754	0.00402	CcSEcCtD
Fentanyl—Abdominal distension—Varenicline—nicotine dependence	0.000742	0.00396	CcSEcCtD
Fentanyl—Dysphagia—Varenicline—nicotine dependence	0.000737	0.00393	CcSEcCtD
Fentanyl—Asthma—Varenicline—nicotine dependence	0.000737	0.00393	CcSEcCtD
Fentanyl—Angina pectoris—Varenicline—nicotine dependence	0.000718	0.00383	CcSEcCtD
Fentanyl—Bronchitis—Varenicline—nicotine dependence	0.000709	0.00378	CcSEcCtD
Fentanyl—Abdominal discomfort—Varenicline—nicotine dependence	0.000706	0.00377	CcSEcCtD
Fentanyl—Sufentanil—OPRM1—nicotine dependence	0.000699	0.0741	CrCbGaD
Fentanyl—Pollakiuria—Varenicline—nicotine dependence	0.000681	0.00363	CcSEcCtD
Fentanyl—Erectile dysfunction—Varenicline—nicotine dependence	0.000679	0.00362	CcSEcCtD
Fentanyl—Weight increased—Varenicline—nicotine dependence	0.000671	0.00358	CcSEcCtD
Fentanyl—Hyperglycaemia—Varenicline—nicotine dependence	0.000665	0.00355	CcSEcCtD
Fentanyl—Infestation—Varenicline—nicotine dependence	0.000657	0.0035	CcSEcCtD
Fentanyl—Infestation NOS—Varenicline—nicotine dependence	0.000657	0.0035	CcSEcCtD
Fentanyl—Depression—Varenicline—nicotine dependence	0.000655	0.00349	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.000651	0.00347	CcSEcCtD
Fentanyl—Alfentanil—OPRM1—nicotine dependence	0.000649	0.0689	CrCbGaD
Fentanyl—Stomatitis—Varenicline—nicotine dependence	0.00064	0.00342	CcSEcCtD
Fentanyl—Conjunctivitis—Varenicline—nicotine dependence	0.000639	0.00341	CcSEcCtD
Fentanyl—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000624	0.0348	CbGpPWpGaD
Fentanyl—Hepatobiliary disease—Varenicline—nicotine dependence	0.000621	0.00331	CcSEcCtD
Fentanyl—Epistaxis—Varenicline—nicotine dependence	0.00062	0.00331	CcSEcCtD
Fentanyl—Sinusitis—Varenicline—nicotine dependence	0.000616	0.00329	CcSEcCtD
Fentanyl—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000615	0.0343	CbGpPWpGaD
Fentanyl—Bradycardia—Varenicline—nicotine dependence	0.0006	0.0032	CcSEcCtD
Fentanyl—Hypoaesthesia—Varenicline—nicotine dependence	0.000587	0.00313	CcSEcCtD
Fentanyl—Hallucination—Varenicline—nicotine dependence	0.000587	0.00313	CcSEcCtD
Fentanyl—Urinary tract disorder—Varenicline—nicotine dependence	0.000582	0.00311	CcSEcCtD
Fentanyl—Oedema peripheral—Varenicline—nicotine dependence	0.000581	0.0031	CcSEcCtD
Fentanyl—Connective tissue disorder—Varenicline—nicotine dependence	0.00058	0.00309	CcSEcCtD
Fentanyl—Urethral disorder—Varenicline—nicotine dependence	0.000578	0.00308	CcSEcCtD
Fentanyl—Methadone—CHRNA10—nicotine dependence	0.000576	0.0611	CrCbGaD
Fentanyl—Visual impairment—Varenicline—nicotine dependence	0.000568	0.00303	CcSEcCtD
Fentanyl—Erythema multiforme—Varenicline—nicotine dependence	0.000558	0.00297	CcSEcCtD
Fentanyl—Diphenoxylate—OPRM1—nicotine dependence	0.000552	0.0586	CrCbGaD
Fentanyl—Eye disorder—Varenicline—nicotine dependence	0.000551	0.00294	CcSEcCtD
Fentanyl—Tinnitus—Varenicline—nicotine dependence	0.00055	0.00293	CcSEcCtD
Fentanyl—Cardiac disorder—Varenicline—nicotine dependence	0.000547	0.00292	CcSEcCtD
Fentanyl—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000541	0.0302	CbGpPWpGaD
Fentanyl—Angiopathy—Varenicline—nicotine dependence	0.000535	0.00285	CcSEcCtD
Fentanyl—Immune system disorder—Varenicline—nicotine dependence	0.000533	0.00284	CcSEcCtD
Fentanyl—Mediastinal disorder—Varenicline—nicotine dependence	0.000531	0.00284	CcSEcCtD
Fentanyl—Chills—Varenicline—nicotine dependence	0.000529	0.00282	CcSEcCtD
Fentanyl—Arrhythmia—Varenicline—nicotine dependence	0.000527	0.00281	CcSEcCtD
Fentanyl—Mental disorder—Varenicline—nicotine dependence	0.000517	0.00276	CcSEcCtD
Fentanyl—Malnutrition—Varenicline—nicotine dependence	0.000513	0.00274	CcSEcCtD
Fentanyl—Erythema—Varenicline—nicotine dependence	0.000513	0.00274	CcSEcCtD
Fentanyl—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000509	0.0284	CbGpPWpGaD
Fentanyl—Flatulence—Varenicline—nicotine dependence	0.000506	0.0027	CcSEcCtD
Fentanyl—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000506	0.0282	CbGpPWpGaD
Fentanyl—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000505	0.0281	CbGpPWpGaD
Fentanyl—Dysgeusia—Varenicline—nicotine dependence	0.000503	0.00268	CcSEcCtD
Fentanyl—Back pain—Varenicline—nicotine dependence	0.000497	0.00265	CcSEcCtD
Fentanyl—Muscle spasms—Varenicline—nicotine dependence	0.000494	0.00263	CcSEcCtD
Fentanyl—Vision blurred—Varenicline—nicotine dependence	0.000484	0.00258	CcSEcCtD
Fentanyl—Tremor—Varenicline—nicotine dependence	0.000481	0.00257	CcSEcCtD
Fentanyl—Ill-defined disorder—Varenicline—nicotine dependence	0.000476	0.00254	CcSEcCtD
Fentanyl—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000475	0.0265	CbGpPWpGaD
Fentanyl—Anaemia—Varenicline—nicotine dependence	0.000474	0.00253	CcSEcCtD
Fentanyl—Agitation—Varenicline—nicotine dependence	0.000472	0.00252	CcSEcCtD
Fentanyl—Malaise—Varenicline—nicotine dependence	0.000463	0.00247	CcSEcCtD
Fentanyl—Vertigo—Varenicline—nicotine dependence	0.000461	0.00246	CcSEcCtD
Fentanyl—Syncope—Varenicline—nicotine dependence	0.00046	0.00246	CcSEcCtD
Fentanyl—Palpitations—Varenicline—nicotine dependence	0.000454	0.00242	CcSEcCtD
Fentanyl—Loss of consciousness—Varenicline—nicotine dependence	0.000451	0.00241	CcSEcCtD
Fentanyl—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000451	0.0251	CbGpPWpGaD
Fentanyl—Cough—Varenicline—nicotine dependence	0.000448	0.00239	CcSEcCtD
Fentanyl—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000447	0.0249	CbGpPWpGaD
Fentanyl—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000445	0.0248	CbGpPWpGaD
Fentanyl—Convulsion—Varenicline—nicotine dependence	0.000445	0.00237	CcSEcCtD
Fentanyl—Hypertension—Varenicline—nicotine dependence	0.000443	0.00236	CcSEcCtD
Fentanyl—Myalgia—Varenicline—nicotine dependence	0.000437	0.00233	CcSEcCtD
Fentanyl—Chest pain—Varenicline—nicotine dependence	0.000437	0.00233	CcSEcCtD
Fentanyl—Arthralgia—Varenicline—nicotine dependence	0.000437	0.00233	CcSEcCtD
Fentanyl—Anxiety—Varenicline—nicotine dependence	0.000436	0.00232	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000434	0.00232	CcSEcCtD
Fentanyl—Discomfort—Varenicline—nicotine dependence	0.000432	0.0023	CcSEcCtD
Fentanyl—Dry mouth—Varenicline—nicotine dependence	0.000427	0.00228	CcSEcCtD
Fentanyl—Oedema—Varenicline—nicotine dependence	0.000419	0.00224	CcSEcCtD
Fentanyl—Infection—Varenicline—nicotine dependence	0.000416	0.00222	CcSEcCtD
Fentanyl—Shock—Varenicline—nicotine dependence	0.000412	0.0022	CcSEcCtD
Fentanyl—Nervous system disorder—Varenicline—nicotine dependence	0.000411	0.00219	CcSEcCtD
Fentanyl—Thrombocytopenia—Varenicline—nicotine dependence	0.00041	0.00219	CcSEcCtD
Fentanyl—Tachycardia—Varenicline—nicotine dependence	0.000409	0.00218	CcSEcCtD
Fentanyl—Skin disorder—Varenicline—nicotine dependence	0.000407	0.00217	CcSEcCtD
Fentanyl—Hyperhidrosis—Varenicline—nicotine dependence	0.000405	0.00216	CcSEcCtD
Fentanyl—Anorexia—Varenicline—nicotine dependence	0.000399	0.00213	CcSEcCtD
Fentanyl—Hypotension—Varenicline—nicotine dependence	0.000391	0.00209	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000382	0.00204	CcSEcCtD
Fentanyl—Insomnia—Varenicline—nicotine dependence	0.000379	0.00202	CcSEcCtD
Fentanyl—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000378	0.021	CbGpPWpGaD
Fentanyl—Dyspnoea—Varenicline—nicotine dependence	0.000374	0.00199	CcSEcCtD
Fentanyl—Somnolence—Varenicline—nicotine dependence	0.000372	0.00199	CcSEcCtD
Fentanyl—Dyspepsia—Varenicline—nicotine dependence	0.000369	0.00197	CcSEcCtD
Fentanyl—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000365	0.0204	CbGpPWpGaD
Fentanyl—Decreased appetite—Varenicline—nicotine dependence	0.000364	0.00194	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000362	0.00193	CcSEcCtD
Fentanyl—Fatigue—Varenicline—nicotine dependence	0.000361	0.00193	CcSEcCtD
Fentanyl—Pain—Varenicline—nicotine dependence	0.000358	0.00191	CcSEcCtD
Fentanyl—Constipation—Varenicline—nicotine dependence	0.000358	0.00191	CcSEcCtD
Fentanyl—Feeling abnormal—Varenicline—nicotine dependence	0.000345	0.00184	CcSEcCtD
Fentanyl—Gastrointestinal pain—Varenicline—nicotine dependence	0.000343	0.00183	CcSEcCtD
Fentanyl—Urticaria—Varenicline—nicotine dependence	0.000333	0.00178	CcSEcCtD
Fentanyl—Abdominal pain—Varenicline—nicotine dependence	0.000331	0.00177	CcSEcCtD
Fentanyl—Body temperature increased—Varenicline—nicotine dependence	0.000331	0.00177	CcSEcCtD
Fentanyl—Hypersensitivity—Varenicline—nicotine dependence	0.000309	0.00165	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000308	0.0172	CbGpPWpGaD
Fentanyl—Asthenia—Varenicline—nicotine dependence	0.000301	0.0016	CcSEcCtD
Fentanyl—Pruritus—Varenicline—nicotine dependence	0.000296	0.00158	CcSEcCtD
Fentanyl—Diarrhoea—Varenicline—nicotine dependence	0.000287	0.00153	CcSEcCtD
Fentanyl—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000285	0.0159	CbGpPWpGaD
Fentanyl—Dizziness—Varenicline—nicotine dependence	0.000277	0.00148	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00027	0.0151	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.000269	0.015	CbGpPWpGaD
Fentanyl—Vomiting—Varenicline—nicotine dependence	0.000266	0.00142	CcSEcCtD
Fentanyl—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000265	0.0148	CbGpPWpGaD
Fentanyl—Rash—Varenicline—nicotine dependence	0.000264	0.00141	CcSEcCtD
Fentanyl—Dermatitis—Varenicline—nicotine dependence	0.000264	0.00141	CcSEcCtD
Fentanyl—Headache—Varenicline—nicotine dependence	0.000262	0.0014	CcSEcCtD
Fentanyl—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000255	0.0142	CbGpPWpGaD
Fentanyl—Nausea—Varenicline—nicotine dependence	0.000249	0.00133	CcSEcCtD
Fentanyl—Dextropropoxyphene—OPRM1—nicotine dependence	0.00024	0.0255	CrCbGaD
Fentanyl—Loperamide—OPRM1—nicotine dependence	0.000229	0.0243	CrCbGaD
Fentanyl—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000229	0.0127	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000223	0.0124	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000215	0.012	CbGpPWpGaD
Fentanyl—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00021	0.0117	CbGpPWpGaD
Fentanyl—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000207	0.0115	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000206	0.0115	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000199	0.0111	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000194	0.0108	CbGpPWpGaD
Fentanyl—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000191	0.0107	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000188	0.0105	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000175	0.00974	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000174	0.00971	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000171	0.00952	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00017	0.00947	CbGpPWpGaD
Fentanyl—Methadone—OPRM1—nicotine dependence	0.000163	0.0173	CrCbGaD
Fentanyl—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000158	0.00882	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000155	0.00865	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000153	0.00852	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00015	0.00834	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000144	0.00803	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000139	0.00774	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000137	0.00762	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000136	0.00759	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.00013	0.00725	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000129	0.0072	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000126	0.00704	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000124	0.00692	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000123	0.00688	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.00012	0.00668	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000117	0.00654	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000115	0.00641	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000114	0.00635	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000109	0.00607	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000108	0.00603	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000107	0.00595	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000101	0.00565	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	9.58e-05	0.00534	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	9.4e-05	0.00524	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	9.35e-05	0.00521	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	9.21e-05	0.00513	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.15e-05	0.0051	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	9.03e-05	0.00503	CbGpPWpGaD
Fentanyl—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	8.9e-05	0.00496	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	8.24e-05	0.00459	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	8.2e-05	0.00457	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	7.35e-05	0.0041	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FGD1—nicotine dependence	7.34e-05	0.00409	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	6.97e-05	0.00388	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	6.93e-05	0.00386	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	6.67e-05	0.00372	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	6.48e-05	0.00361	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	6.44e-05	0.00359	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—FGD1—nicotine dependence	6.43e-05	0.00359	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	5.85e-05	0.00326	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	5.68e-05	0.00317	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—FGD1—nicotine dependence	5.44e-05	0.00303	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	5.35e-05	0.00298	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	5.31e-05	0.00296	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	4.82e-05	0.00269	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	4.8e-05	0.00268	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	4.66e-05	0.0026	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP2A7—nicotine dependence	4.59e-05	0.00256	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—WASF2—nicotine dependence	4.57e-05	0.00254	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—WASF1—nicotine dependence	4.38e-05	0.00244	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	4.23e-05	0.00236	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—WASF2—nicotine dependence	4e-05	0.00223	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	3.94e-05	0.0022	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	3.94e-05	0.00219	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—WASF1—nicotine dependence	3.84e-05	0.00214	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	3.58e-05	0.00199	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	3.46e-05	0.00193	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—WASF2—nicotine dependence	3.38e-05	0.00189	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP2A7—nicotine dependence	3.32e-05	0.00185	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—WASF1—nicotine dependence	3.24e-05	0.00181	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—DRD2—nicotine dependence	2.85e-05	0.00159	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2A7—nicotine dependence	2.51e-05	0.0014	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—DRD2—nicotine dependence	2.5e-05	0.00139	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—DRD2—nicotine dependence	2.11e-05	0.00118	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2A7—nicotine dependence	1.54e-05	0.00086	CbGpPWpGaD
